Core Viewpoint - Multiple companies in China conducted share buybacks on October 17, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1][2] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 10.70 million shares for a total of 494 million yuan, with a year-to-date total of 27.30 million shares, representing 0.110% of its total share capital [2] - Four Seasons Pharmaceutical (00460) repurchased 15 million shares for 21.76 million yuan, with a year-to-date total of 59.60 million shares, representing 0.647% of its total share capital [2] - Mengniu Dairy (02319) repurchased 1.20 million shares for 16.97 million yuan, with a year-to-date total of 18.52 million shares, representing 0.473% of its total share capital [2] Group 2: Other Notable Buybacks - VITASOY International (00345) repurchased 1.02 million shares for 8.20 million yuan, with a year-to-date total of 566.60 million shares, representing 0.540% of its total share capital [2] - Zhongtong Express-W (02057) repurchased 445,000 shares for 8.41 million yuan, with a year-to-date total of 5.07 million shares, representing 0.630% of its total share capital [2] - Huazhong Media (00685) repurchased 500,000 shares for 50,000 yuan, with a year-to-date total of 225.60 million shares, representing 0.139% of its total share capital [2]

Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3] Summary by Category Share Buyback Activity - On October 17, 康臣药业 repurchased 317,000 shares at a price range of HKD 14.970 to HKD 15.200, totaling HKD 4.7791 million [2] - The stock closed at HKD 15.070 on the same day, reflecting a decrease of 2.65% with a total trading volume of HKD 22.5955 million [2] - Since October 14, the company has conducted buybacks for four consecutive days, acquiring a total of 937,000 shares for a cumulative amount of HKD 14.368 million, during which the stock price fell by 5.81% [2] Year-to-Date Buyback Summary - Year-to-date, 康臣药业 has executed 22 buyback transactions, repurchasing a total of 6.132 million shares for a total expenditure of HKD 72.8991 million [2] Detailed Buyback Data - The buyback details include: - October 16: 200,000 shares at a maximum price of HKD 15.600, totaling HKD 3.1182 million [2] - October 15: 100,000 shares at a maximum price of HKD 15.840, totaling HKD 1.5757 million [2] - October 14: 320,000 shares at a maximum price of HKD 15.620, totaling HKD 4.8951 million [2] - Other notable buyback dates include July 18, July 16, and July 15, with varying amounts and prices [2][3]

康臣药业(01681)发布公告，公司于2025年10月17日斥资477.91万港元回购31.7万股股份，每股回购价格 为14.97-15.2港元。 ...

Group 1 - The company, 康臣药业 (Kangchen Pharmaceutical), announced a share buyback on October 17, 2025, spending HKD 4.7791 million to repurchase 317,000 shares [1] - The buyback price ranged from HKD 14.97 to HKD 15.20 per share [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - 康臣药业 plans to repurchase 317,000 shares at a total cost of HKD 4.7791 million [1] - The buyback price per share ranges from HKD 14.97 to HKD 15.20 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年10月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | ...

Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on October 16, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 4 million shares for a total of 192 million [1] - Mengniu Dairy (02319) repurchased 1 million shares for 14.44 million [2] - Yun Gongchang (N23027) repurchased 2.01 million shares for 8.19 million [2] Group 2: Cumulative Buyback Data - Xiaomi Group-W has a cumulative buyback of 16.59 million shares, representing 0.060% of total share capital [2] - Mengniu Dairy has a cumulative buyback of 17.32 million shares, representing 0.443% of total share capital [2] - Yun Gongchang has a cumulative buyback of 20.62 million shares, representing 4.483% of total share capital [2] Group 3: Other Notable Buybacks - Lianyi Rong Technology-W (09959) repurchased 2.39 million shares for 7.48 million, with a cumulative total of 60.47 million shares, representing 2.830% of total share capital [2] - Kangning Jiere Pharmaceutical-B (09966) repurchased 400,000 shares for 5.48 million, with a cumulative total of 801,000 shares, representing 0.083% of total share capital [2] - Guisheng Tongqiao-B (02190) repurchased 50,000 shares for 1.24 million, with a cumulative total of 330,350 shares, representing 1.009% of total share capital [2]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Company Summary - 康臣药业 plans to repurchase 200,000 shares at a total cost of HKD 3.1182 million [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating a commitment to enhancing shareholder value through the repurchase of shares [1] Group 1 - 康臣药业 plans to repurchase 200,000 shares at a total cost of HKD 3.118 million [1] - The buyback is scheduled for October 16, 2025, reflecting the company's strategy to manage its capital effectively [1]

| 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年10月15日 | | 847,973,407 | | 0 | | 847,973,407 | | 1). 其他 (請註明) | | | | % | | | | | 見B部分 | | | | | | | | | 變動日期 | 2025年10月16日 | | | | | | | | 於下列日期結 ...